King of Prussia, PA, United States of America

Kristen E Belmonte

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristen E Belmonte. Retrieved from https://idiyas.com/inventor/kristen-e-belmonte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kristen E Belmonte: Innovator in Muscarinic Acetylcholine Receptor Antagonists

Introduction

Kristen E Belmonte is a notable inventor based in King of Prussia, PA (US). She has made significant contributions to the field of pharmacology, particularly in the development of muscarinic acetylcholine receptor antagonists. Her work has implications for various therapeutic applications.

Latest Patents

Kristen holds 1 patent for her invention titled "Muscarinic Acetylcholine Receptor Antagonists." This patent outlines methods of using these antagonists, which are crucial for advancing treatment options in related medical fields.

Career Highlights

Kristen is currently employed at Glaxo Group Limited, where she continues to innovate and contribute to the pharmaceutical industry. Her expertise in receptor antagonists has positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Kristen has collaborated with talented individuals such as Jakob Busch-Petersen and Dramane Ibrahim Laine. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Kristen E Belmonte is a pioneering inventor whose work on muscarinic acetylcholine receptor antagonists is shaping the future of pharmacological treatments. Her contributions are vital to the ongoing advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…